Childbearing with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Large International Survey of Outcomes and Complications

Int J Environ Res Public Health. 2023 Oct 21;20(20):6957. doi: 10.3390/ijerph20206957.

Abstract

One in 20 births could be affected by hypermobile Ehlers-Danlos syndrome or Hypermobility Spectrum Disorders (hEDS/HSD); however, these are under-diagnosed and lacking research. This study aimed to examine outcomes and complications in people childbearing with hEDS/HSD. A large online international survey was completed by women with experience in childbearing and a diagnosis of hEDS/HSD (N = 947, total pregnancies = 1338). Data were collected on demographics, pregnancy and birth outcomes and complications. Participants reported pregnancies in the UK (N = 771), USA (N = 364), Australia (N = 106), Canada (N = 60), New Zealand (N = 23) and Ireland (N = 14). Incidences were higher in people with hEDS/HSD than typically found in the general population for pre-eclampsia, eclampsia, pre-term rupture of membranes, pre-term birth, antepartum haemorrhage, postpartum haemorrhage, hyperemesis gravidarum, shoulder dystocia, caesarean wound infection, postpartum psychosis, post-traumatic stress disorder, precipitate labour and being born before arrival at place of birth. This potential for increased risk related to maternal and neonatal outcomes and complications highlights the importance of diagnosis and appropriate care considerations for childbearing people with hEDS/HSD. Recommendations include updating healthcare guidance to include awareness of these possible complications and outcomes and including hEDS/HSD in initial screening questionnaires of perinatal care to ensure appropriate consultation and monitoring can take place from the start.

Keywords: Ehlers–Danlos; Mast Cell Activation syndrome (MCAS); birth; hypermobility; incidence; labour; maternity; pregnancy; premature birth; women’s health and wellbeing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ehlers-Danlos Syndrome* / complications
  • Ehlers-Danlos Syndrome* / epidemiology
  • Female
  • Humans
  • Infant, Newborn
  • Joint Instability*
  • Pregnancy
  • Surveys and Questionnaires
  • Uterine Hemorrhage

Supplementary concepts

  • Ehlers-Danlos syndrome type 3

Grants and funding

This research was funded by the Coventry University “Enterprise, Exchange and Engagement” internal pump priming grant.